Breakpoints

#78 – New Therapies in HIV: The Long Road to Long-acting Antiretrovirals - Are We There Yet?

Apr 28, 2023
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 2min
2
The Importance of Cobbotegraviral Pivoring in HIV Treatment
02:23 • 2min
3
Cabotage Vereal Pivrein: A New Drug for HIV Treatment
03:53 • 2min
4
The Benefits of Taking an Injectable Therapy
05:55 • 2min
5
The Stigma of HIV Medication
08:05 • 2min
6
The Role of HIV Therapy in the Treatment of HIV
09:57 • 2min
7
Capri-Pivirin for Viremia and Advanced HIV Diseases
11:47 • 2min
8
The Benefits of Long-Action Antipsychotics
13:55 • 2min
9
Cabotage for PrEP: The Pharmacokinetic Tail and Resistance Development
16:08 • 2min
10
The Role of PrEP in HIV Prevention
18:37 • 2min
11
The Importance of Prior Authorizations in the Pharmacist's Clinic
20:27 • 2min
12
How to Use Cabotagevir for PrEP in Your Clinic
22:07 • 2min
13
How to Get Your First Dose on the Day You Arrive
23:40 • 2min
14
Cabotegravirine and the Health System
25:45 • 2min
15
How to Manage the Increased Workload in an HIV Clinic
27:23 • 2min
16
How to Implement a Prior Authorization Service
29:19 • 4min
17
The Logistics of Getting Started
32:52 • 2min
18
The Biggest Logistic Challenge for a Patient
34:24 • 2min
19
The Importance of Resistance to Role Pibberine
36:53 • 4min
20
The Importance of Scheduling a Lead in for HIV Treatment
41:14 • 2min
21
Oral Rilpivoring and the Adverse Effects
43:01 • 2min
22
The Role of Bees in Long-Acting Therapies
44:38 • 3min
23
The Future of HIV Therapy
47:31 • 2min
24
The Importance of Lena Capaver in HIV Treatment
49:06 • 3min
25
The Future of HIV Therapy
51:41 • 2min
26
The Future of HIV Prevention
53:25 • 2min
27
The Future of Antimicrobial Therapy
55:49 • 2min